Company Filing History:
1 out of 517 
1 out of 4,455 
1 out of 1,361 
Years Active: 2025
Title: Stephen P. Soltoff: Innovator in Targeted Therapy
Introduction
Stephen P. Soltoff is a notable inventor based in Waban, MA (US). He has made significant contributions to the field of targeted therapy, particularly through his work on CDCP1 antibodies and antibody drug conjugates. His innovative approach aims to enhance therapeutic options for patients.
Latest Patents
Stephen P. Soltoff holds 1 patent related to his research. The patent focuses on materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy. This advancement has the potential to improve treatment outcomes in various medical conditions.
Career Highlights
Throughout his career, Soltoff has worked with prestigious organizations, including Beth Israel Deaconess Medical Center and Pfizer. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Stephen P. Soltoff has collaborated with esteemed colleagues such as Lewis C. Cantley and Brooke M. Emerling. These partnerships have contributed to the advancement of research and development in targeted therapies.
Conclusion
Stephen P. Soltoff's work in the field of targeted therapy exemplifies the impact of innovation in medicine. His contributions continue to pave the way for new treatment options and improved patient care.